Monthly Meeting
Local Seminars
The Nucleus
Contact Us
 
 
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

NEWS
 

NESACS 2020 Election Results
Chair- Elect:
230
Carol Mulrooney (w)
161
Patrick Gordon
     
     
Treasurer:
357
Ashis Saha (w)
     
     
Trustee:
220
Cathy Costello (w)
160 Ruth Tanner
     
     
Nominating Committee: (2)
279
Lisa Marcaurelle (w)
225
Doris Lewis (w)
116 Anyin Li
71 Matthias Eberstadt
   
   
Norris Committee: (2)
225
Christine Caputo (w)
201
Patricia A. Mabrouk (w)
156
George O’Doherty
113 Chris Moreton
   
 
Councilor/Alternate Councilor:
256
Carol Mulrooney (c)
220
Patricia A. Mabrouk (c)
194
Caitlyn Mills (c)
193
Anna W. Sromek (c)
191
Michael Singer (c)
179
Patrick M. Gordon (a)
177
Meredith Ward (a)
167
Katie Rubino (a)
166
Mariam Ismnail (a)
159
Lori Ferrins (a)
155
Michael P. Filosa
154
Natalie LaFranzo
127
Raj (SB) Rajur
125 Steve Canham
116 Jens Breffke
114 Mary Mahaney
107 Kap-Sun Yeung
97 Ray Lam
93 Ashis Saha
90 Hicham Fenniri
77 Daljit Matharu
   
Director-at-Large: (2)
227
Dr John Neumeyer (w)
221
Dr. James U. Piper (w)
205 Dr. Ralph Scannell
   

AUTM Publishes Licensing Guidelines to Promote Collaborations for COVID-19 Related Innovations
By Katherine Ann Rubino, Patent Attorney, Caldwell Intellectual Property Law
On April 17, 2020 the Association of University Technology Managers (AUTM) released licensing guidelines for COVID-19 related inventions.[i] As the COVID-19 pandemic continues to ravage across the globe, AUTM has compiled a list of current ongoing research, clinical trials, licensing guidelines, and potential treatments, in order to share useful information with members around the world.[ii] AUTM is a non-profit organization that supports the development of academic research. Members of AUTM include over 800 universities, research centers, hospitals, businesses, and government organization worldwide.[iii]
The licensing guidelines released by AUTM were developed to provide guidance for technology transfer offices in order to promote non-exclusive royalty-free licenses in exchange for spurring innovation that help address this public health crisis.[iv]
The licensing guidelines specify that: Technology transfer accelerates innovations that impact society and promotes the broad distribution of public health solutions. We encourage intellectual property (IP) owners to adopt a COVID-19 licensing strategy that facilitates rapid pandemic response by licensees and to make the execution of associated transactions a top priority.
For most technologies, where legally possible, this strategy is best accomplished by adopting time-limited, non-exclusive royalty-free licenses, in exchange for the licensees’ commitment to rapidly make and broadly distribute products and services to prevent, diagnose, treat and contain COVID-19 and protect healthcare workers during the pandemic (as defined by the World Health Organization).
Licenses may subsequently convert to a more typical commercial license as appropriate. Licenses must also preserve the licensor’s freedom to publish and use the intellectual property for teaching and research.[v]
Currently, over eighty-five universities, hospitals, and research institutions located all around the globe have signed on to participate in the licensing guidelines established by AUTM.[vi] Further researchers, universities, and institutions interested in sharing research and news can contact AUTM to post information related to COVID-19 related research or innovations. This information can be posted or searched without an AUTM membership. For more information, interested participants can visit https:// autm.net/about-tech-transfer/ covid19/about-covid_19-research.[vii]

[i] https://autm.net/about-tech-transfer/ covid19/covid-19-licensing-guidelines
[ii] https://autm.net/about-tech-transfer/ covid19/about-covid_19-research
[iii] https://autm.net/about-autm/who-we-are
[iv] https://autm.net/about-tech-transfer/ covid19/covid-19-licensing-guidelines
[v] Id.
[vi] Id.
[vii] https://autm.net/about-tech-transfer/ covid19/about-covid_19-researc
h


Dorothy Phillips Receives Lifetime Achievement Award from NOBCChE
The National Organization of Black Chemists and Chemical Engineers (NOBCChE) has awarded Dorothy J. Wingfield Phillips, Ph.D. a Lifetime Achievement Award at its September 25, 2020 Virtual Awards Meeting.
Dorothy has been for many years a top leader in the American Chemical Society both in NESACS and nationally. She is currently serving her third term on the Board of Directors of the ACS as a Director-at-Large.
Dorothy is originally from Tennessee and she is one of eight children. Her father was a Baptist minister. Her parents were supportive of her education and she originally attended Tennessee State before transferring to Vanderbilt in 1966. In 1967 Phillips was the first African-American woman to complete a bachelor’s degree at Vanderbilt University. She completed her doctoral studies at the University of Cincinnati, and, again, was the first African-American woman in Cincinnati to earn a PhD in chemistry.
In 1973 the joined the American Chemical Society. Phillips joined the Dow Chemical Company as a bench scientist. Phillips joined the Waters Corporation in 1984, where she worked in research and development. After an almost thirty-year career, Phillips retired from the Waters Corporation in 2013 as Director of Strategic Marketing.
Dorothy’s late husband, James Phillips, was also a chemist, an active member of NESACS and the 2019 recipient of the Henry A. Hill Award. She has three children, Anthony, Crystal and Vicki and many grandchildren.

Awards and honors:

1994 1994 University of Cincinnati Distinguished Alumni
2004 American Chemical Society-Nashville Section, Salute to Excellence Award
2006 Vanderbilt University, Unsung Heroine Award
2006 American Chemical Society Northeastern Section, Henry A. Hill Award
2008 American Chemical Society-Santa Clara Valley Section, Shirley B. Radding Award
2008 Waters Corporation Leadership Award for Outstanding Contributions
2008 Vanderbilt University, Dr. Dorothy Wingfield Phillips Award for Leadership
2010 Fellow of the American Chemical Society
2011 New England Institute of Chemists Distinguished Chemist Award
2015 Vanderbilt University, Dr. Dorothy J. Wingfield Phillips Endowed Chair
2017 Vanderbilt University, Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellowships
2019 Vanderbilt University, 2019 Class of Vanderbilt Trailblazers
 

NESACS Members Named ACS Fellows for 2020
 
 
Contribution to the science/profession: Recognized for creative insights in the biophysics and biochemical functions of DNA repair and other enzymes, strong commitments to undergraduate and graduate education, and to the professional development of faculty.
 
Contribution to the ACS community: Recognized for outstanding service to the Chemical Toxicology Division, the Committee on Economic and Professional Affairs, and a tireless commitment to mentoring early career scientists and future faculty.
Penny J. Beuning    
Northeastern University    
 
     
 
Contribution to the science/profession: Experiments establishing the mechanism of ribonucleotide reductases, polyester synthases, and natural product DNA cleavers; use of chemical investigations to solve biological problems.
 
Contribution to the ACS community: Involved in making Biochemistry a requirement for all undergraduate chemists; Program Chair and Head of the Biological Chemistry Division; felt equally at home in the Bioinorganic/Inorganic Division.
JoAnne Stubbe    
Massachusetts Institute of Technology (Emeritus)    
     
List of all 2020 ACS Fellows...

U.S. team earns four gold medals at the 52nd International Chemistry Olympiad

Top row (from left): Anugrah Chemparathy, Joseph Houck, Alex Li
Middle row (from left): Ananthan Sadagopan, Melissa Barranger Mathys, Alec Zhu
Bottom row: Esther Hines
Credit: Joseph Houck

The American Chemical Society (ACS) is proud to announce that Team USA earned four gold medals at the 52nd International Chemistry Olympiad, with one student earning the top gold medal.

The four members of the U.S. National Chemistry Olympiad (USNCO) team are:
  • Anugrah Chemparathy, Dougherty Valley High School, CA, California Local Section
  • Alex Li, Lexington High School, MA, Northeastern Local Section
  • Ananthan Sadagopan, Westborough High School, MA, Central Massachusetts Local Section
  • Alec Zhu, Lexington High School, MA, Northeastern Local Section

Alex Li won the top gold medal in the competition, placing first in the overall ranking of students.
A total of 235 students from 60 countries competed at this year’s remote-access International Chemistry Olympiad, which was coordinated from Istanbul.

“ACS congratulates Team USA on their outstanding performance under extraordinary circumstances in this year’s International Chemistry Olympiad,” says ACS CEO Thomas Connelly Jr., Ph.D. “As a proud sponsor of the U.S. team, we are always inspired to see the dedication of these students throughout the Olympiad process. We are especially excited this year to celebrate the team’s success in earning four gold medals, including the top gold medal in the competition.”

Three mentors supported Team USA leading up to the international competition: Melissa Barranger Mathys, Ph.D., Ursuline College in Pepper Pike, Ohio, head mentor; Joseph Houck, Ph.D., Penn State University in University Park, Pa., college mentor; and Esther Hines, Billerica Memorial High School in Billerica, Mass., high school mentor.

Previously, Team USA won four gold medals in 2017 and 2018, and members of the U.S. team earned the top gold medals in 1999 and 2000.
ACS has sponsored the American team annually since the U.S. joined the Olympiad in 1984. Principal funding is through the ACS Donald F. and Mildred Topp Othmer Chemistry Olympiad Endowment, with additional support from other donors. For a complete list of donors, visit www.acs.org/olympiad.
The International Chemistry Olympiad originated with Czechoslovakia, Poland and Hungary in 1968. Soon, other Eastern European countries joined the event; Western Europe began participating in 1974.
The first U.S. team competed in 1984, winning one silver and two bronze medals.
The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and its people. The Society is a global leader in providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, eBooks and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a specialist in scientific information solutions (including SciFinder® and STN®), its CAS division powers global research, discovery and innovation. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
Read this announcement on the ACS website.

COVID-19: Compliance is Key
By Elina N. Khachiyan, Esq., RAC
I am a rule follower. Therefore, it is no surprise that a huge part of my practice is focused on compliance. So, you can probably guess that when the directive on social distancing came out, I took it seriously.
What is compliance? In general, compliance means to conform to a rule, a standard, a policy, a regulation, a law.
In my practice I focus primarily on Food and Drug Administration (FDA) related regulatory compliance. This means that a company which is subject to the FDA, including but not limited to, a pharmaceutical supplier, a food importer, a medical device manufacturer, must comply with the regulations under the FDA as they apply to those products.
If, however there is a deviation from compliance, negative consequences arise which range from an FDA product hold to an issuance of a Warning Letter, and so on. Deviations come in all sizes but ultimately all deviations are costly and time consuming to correct. Therefore, the best approach is the preventative approach; to have all the necessary measures in place to ensure that there are very little to no deviations.
Which brings me back to the situation we are dealing with today – COVID-19.
The current rule on social distancing is one we are all subject to. Compliance of this rule means we must maintain distance from others for the protection of others and ourselves and for the ultimate purpose of mitigating the damages arising out of this situation, and ultimately eliminating it.
However, every time there is a deviation from compliance, there are in fact negative consequences, costly for sure as we have seen by the changes in our economy. But also, time consuming to correct because as compliance decreases, the more reach this virus has, and the more resources and time
is required to stop it.
In short, compliance in key and it must be taken seriously, in industry and in life.
Elina N. Khachiyan, Esq., RAC, is a Massachusetts based practicing attorney, focused on pharmaceutical, chemical,
food, and medical device regulatory matters. Elina has been working in various roles, including regulatory, within the
pharmaceutical industry for over 10 years. Khachiyan holds a Juris Doctorate, a Bachelor’s in Chemistry and Secondary
Education, as well as various industry certifications, including three RAC Credentials. She is the founder of Elina Khachiyan Consulting, LLC, a law practice focused on assisting businesses in navigating the complexities of regulatory compliance.

Report from Malta IX
Morton Hoffman, Boston University
Treasurer, Malta Conferences Foundation

The Ninth Biennial Malta Conference (Frontiers of Science: Innovation, Research, and Education in the Middle East; Malta IX), which was held in the Republic of Malta on December 8-13, 2019, brought together 100 scientists, entrepreneurs, postdocs, and graduate students from 15 Middle East countries (Bahrain, Egypt, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Authority, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates), Morocco, and Pakistan, among whom were influential academic and industrial chemists, and environment researchers.  Approximately 35% of the participants were women, which is good for a science gathering, in general, and significant for the Middle East, in particular.
The goal of the biennial conference (and its eight preceding ones since 2003) was to serve as the facilitator of the search for solutions to the scientific problems that face the region, and to do so in the absence of geopolitical constraints.  The participants heard lectures by Nobel laureates and other eminent scientists, participated in workshops, made presentations, and engaged in networking toward the establishment of collaborations.  At this time, more than 700 Middle East scientists and 16 Nobel laureates are part of the Malta Conferences network.
The representatives from Pakistan at Malta IX were particularly interested in exploring how the “Malta model” could be the basis for developing and maintaining contacts with their scientific colleagues in India.
In the opening ceremony, Zafra Lerman, President of the Malta Conferences Foundation <https://www.maltaconferencesfoundation.org/>, emphasized the recognition and respect that the Conferences have achieved by introducing the dignitaries, who then remained to greet the participants and interact with them.  Present were George Vella, President of the Republic of Malta; Stuart Gill, OBE, British High Commissioner for Malta; Fadila Boughanemi, Deputy Head of Research and Innovation of the European Union; Roberto Tanzi-Albi, Senior Adviser at the Ministry of Foreign Affairs of Finland; Mark Shapiro, Chargé d’Affaires at the American Embassy in Malta.
Plenary lectures were given by Nobel laureates, Ada Yonath (Weizmann Institute of Science, Israel; Chemistry, 2009) and Ben Feringa, (University of Groningen, Netherlands; Chemistry, 2016), and by internationally known chemists, Omar Yaghi (University of California, Berkley), Mohamed El-Naggar (University of Southern California), and Omar Farha (Northwestern University), all three of whom were born and raised in the Middle East.  Anne Dare, U.S. Agency for International Development (USAID) Middle East Regional Cooperation (MERC) Program, delivered a keynote lecture.
Malta IX introduced an important new structure for the workshops compared to the previous Conferences so as to address more effectively the issues of water scarcity, air pollution, environmental degradation, and other topics, in order to focus attention toward meaningful changes in the region.  All the workshops were interactive and were co-chaired by a chemist and an entrepreneur in order to promote new ideas and pave the way for new startups.  The participants presented their research in guided poster sessions, which preceded the workshops, in the following topical groups:
  • Nanoscience, Nano-bioscience, and Nanotechnology
  • Medicinal Chemistry: Biotechnology, Organic and Biochemistry, Biophysics
  • Sustainability of Resources: Energy and Materials
  • Environment: Air, Water, and Soil
  • Women in Science Forum
  • Science and Technology Education at all Level
A special workshop was held on chemical, biological, and nuclear security in collaboration with the Organisation for the Prohibition of Chemical Weapons (OPCW), which examined the scientific, educational, and regulatory frameworks for safety in facilities involving dangerous chemicals and ionizing radiation sources.  The new forum for women in science was held every day during lunchtime.
A total of 52 oral and poster presentations were made.  The posters were on display throughout the entire meeting, and were presented by the researchers to the interested participants, which were extended into the guided discussion groups, providing opportunities for in-depth interpretation of the material and intense interactions.
The closing session summarized the discussions and outcomes in the various workshops, and emphasized the great need for the exchange of information and scientists across borders.  The participants enthusiastically endorsed the motion to hold Malta X in the Republic of Malta in December 2021, marking 20 years since the work began on the first Malta Conference within Subcommittee IV (Human Rights and Scientific Freedom) of the ACS International Activities Committee (IAC).
Malta IX was supported by co-sponsorship grants from, among others, Alexander von Humboldt Foundation (Germany), Korea Chemical Industry Research Group, OPCW, UNESCO, Committee of Concerned Scientists, Chemical Abstracts Service, ACS Publications, and the ACS Board of Directors; the latter contribution subsidized the cost of attendance at the conference for 15 young people from the Middle East.
The success of the Malta Conferences, as measured by the interest of potential participants to attend and the number of collaborations that have been established, can be attributed to the fact that the conferences are held in a “neutral” country outside the region, where there is the possibility for everyone to get a visa to attend (albeit with a lot of hard work to overcome many obstacles), that participants are carefully vetted in order to avoid potentially dangerous situations, and that science, not politics, is the focus.
As was noted in the guest editorial by Zafra Lerman and Emma Zajdela, a Ph.D. student at Northwestern University, in the March 16, 2020, issue of Chemical & Engineering News: Imagine walking into a room and encountering several round tables, each with 10 scientists from countries or regions whose governments are hostile to one another, and those scientists are discussing potential scientific collaborations with civility and friendship.  At one table, for example, were representatives from Syria, Iraq, Iran, Gaza, Israel, Palestine, Saudi Arabia, Qatar, Egypt, and Jordan.  Where else in the world can that happen?  As one participant said, “Only at the Malta Conferences.”

Malta Conferences Use Science Diplomacy as a Bridge to Peace in the Middle East
Zafra Lerman and Emma Zajdela
C&EN, Volume 98, Issue 10, March 16, 2020
This is a guest editorial by Zafra Lerman, President of the Malta Conferences Foundation, and Emma Zajdela, a Ph.D. student at Northwestern University.
Chemistry provides hope for peace and understanding in one of the most troubled regions of the world: the Middle East. Imagine walking into a room and encountering several round tables, each with 10 scientists from countries or regions whose governments are hostile to one another, and those scientists are discussing potential scientific collaborations with civility and friendship. At one table, for example, were representatives from Syria, Iraq, Iran, Gaza, Israel, Palestine, Saudi Arabia, Qatar, Egypt, and Jordan. Where else in the world can that happen? As one participant said, “Only at the Malta Conferences.”
Every two years since 2003, the Malta Conferences have provided an opportunity “to identify unique opportunities for collaboration to meet the scientific and technological challenges of the region.” The Malta IX Conference, which was held at the end of 2019 under the theme “Frontiers of Science: Innovation, Research, and Education in the Middle East,” was no different. The event gathered together scientists, entrepreneurs, postdocs, and students from 15 countries or regions from the Middle East, plus Morocco and Pakistan. These scientists participated in talks and workshops with several Nobel laureates to seek solutions to problems beyond geopolitics that this part of the world faces. To date, more than 700 Middle Eastern scientists and 16 Nobel laureates are in the Malta Conferences network.
A challenge that has been a constant since the Malta Conferences were launched is securing visas for participants. Although the preparations for the event started two years in advance, several participants from Iran, Egypt, Jordan, Syria, Gaza, Palestine, and Pakistan had still not received their visas 48 hours
before the conference was set to start. With the help of the Maltese Minister for Education and Employment – and the organizers, who endured many sleepless nights – the authorities at the last minute agreed to issue visas to the scientists upon their landing in Malta.
Malta IX had a makeover. Organizers implemented a new structure for the workshops to create more meaningful change for the region so that the issues of water scarcity, air pollution, environmental degradation, and more can be addressed more effectively. All the workshops were interactive and co-chaired by a chemist and an entrepreneur to promote new ideas and pave the way for new start-ups. The Middle Eastern participants presented their research in a guided poster session, which preceded the workshops. The topics included medicinal chemistry; biotechnology; nanoscience; chemical, biological,
and nuclear security; energy and materials; and more.
Representatives from different funding agencies from around the world attended the workshops and discussed the possibility of financial support for several projects.
At Malta IX, efforts to include more women from the Middle East paid off: 35% of the participants were
women, which is good for a science gathering in general and for the Middle East in particular. A special forum to promote women in science in the Middle East and encourage young girls to pursue careers in science was held every lunchtime throughout the conference. Diversity efforts during Malta IX also meant that the number of young people was especially high, as the American Chemical Society subsidized the cost of attendance at the conference for 15 young people from the Middle East.
The participants of Malta IX had an opportunity to network at events hosted by the Ministry for Foreign Affairs of Finland, the British High Commission in Malta, and the Malta Council for Science and Technology, which sponsored the closing ceremony at the science museum.
In his speech at the opening ceremony, George Vella, President of Malta, said: “It is heartening to see representatives from so many countries from the Middle East, including Nobel laureates, coming together to discuss ways forward and cooperation in science for the well-being of the people of the region
and beyond.”
This article is reproduced with permission from Chemical & Engineering News (© American Chemical Society).
The article was first published on March 16, 2020.

 
American Chemical Society
258th ACS National Meeting
San Diego, CA
August 25-29, 2019
Councilor Talking Points; Summary of Governance Issues and Actions
Click to read full report ...

The R&D Tax Credit – Catalyzing
Innovation in the Chemicals Industry
Has your company designed, developed or produced new or improved products by experimenting with new formulations, materials or ingredients? Has your company experienced failed batch trials or experimented with scale-up processes for existing products? Has your company attempted to develop new production processes, techniques or methods to increase yields, reduce waste or otherwise improve manufacturing efficiency?
If the answer to any of these questions is yes, then there is a strong chance that your company will benefit from a Research and Development (“R&D”) tax credit study. Increasingly, business management teams are recognizing the importance of taking advantage of the R&D tax credit as a powerful incentive for remaining competitive and refueling critical innovation efforts.
The Chemicals Industry and the R&D Tax Credit Opportunity
The federal R&D tax credit is available to taxpayers who incur expenses for qualified research activities (QRAs) conducted within the US. The credit is comprised primarily of the following types of qualified research expenses (QREs): Wages paid to employees who attempt to develop or support new or
improved products or processes, supplies used for new product development or experimentation, and outside contractors who perform QRAs on behalf of the taxpayer. The purpose of the R&D credit is to offset some financial burden that companies assume by undertaking high risk, high reward development
projects. Many states offer similar research credits which may be claimed additionally once the federal credit has been calculated.
The chemicals industry is an essential component of the U.S. economy, driving innovation for every other sector. The industry’s approximately 10,000 firms produce more than 70,000 products, accounting for more than $800 billion in revenue and touching 96 percent of all manufactured products.
Companies within the chemical industry frequently encounter technical issues related to new product development, compliance with safety and regulatory standards, product yield, product purity and scalability. Technical issues can also arise when companies attempt to improve their product development efficiency by incorporating new Agile methodology. Supply chain management has become increasingly important for chemical companies as they struggle to remain competitive. Research to adopt and integrate lean manufacturing, just-in-time inventory, Six Sigma and Kaizen principles to optimize manufacturing processes and methods are employee activities that may qualify for the R&D tax credit.
Examples of Qualifying Initiatives and Activities for Chemical Companies
  • Designing and developing new products – particularly products that are safer, more effective, have increased functionality, better performance or longer shelf life
  • Researching and testing to identify new applications for existing chemical products
  • Experimenting to gain compliance with new domestic or foreign regulatory requirements
  • Design and development of new testing methods or protocols
  • Product modifications to increase yield or decrease reaction times
  • Improving manufacturing technologies, processes or techniques Experimenting with new software or technologies for product or process improve, Anchinments
  • Research and process developments
    for ISO Certifications
Actual Examples from Anchin’s R&D Practice - New Product Development
One of our chemical industry clients had been researching for a renewable wood byproduct to use as a new raw material in its polyurethane foam line of products. It ultimately identified that Lignin, often used in the paper industry, could now serve as a new viable raw material for the chemical industry due to its recent increase in supply and availability. There were very few commercially available lignin-based products which presented the client with a significant market opportunity. The company is now developing the first of its kind commercially available liquid lignin polyol for the polyurethane industry. While the company had considerable prior experience with propylene oxide reactions, the handling of lignin as a chemical feedstock was entirely new to their team of scientists.
New Process Development
Company set out to develop a reliable and cost-effective manufacturing process to produce Electronic grades of two new products which are sold as ALD (Atomic Layer Deposition) precursors. The challenges encountered during the project development were to create a process that would generate a cost-effective high yield and consistently deliver high enough purity to meet the quality standards. The project investigated the synthesis and purification using a new synthetic route. During the project, purity and yield were evaluated to develop a process that would reliably produce a cost-effective final product.
Maximizing the yield of the process was essential for enabling manufacture of commercially viable products.
Anchin’s R&D Practice
We are skilled and experienced at identifying qualifying projects and initiatives within each area of your business and we are experts at examining and capturing all allowable expenses towards your company’s research credit. Our dedicated team has decades of experience and is familiar with important issues in
every sector of the chemicals industry. Anchin ensures that our clients maximize the R&D tax credit opportunity available to them.
The key to accurately calculating R&D tax credits is distinguishing between qualified and nonqualified research activities and expenses. The determination cannot be made by a company’s accounting or project management systems. Many allowable expenses can be overlooked by taxpayers who do not work with R&D experts to identify all of their potentially qualifying expenses. Equally important to properly
calculating the R&D tax credit for your company is properly documenting the expenses in a way that will withstand IRS audit. Anchin will work with your technical employees to capture critical details which illustrate how your company’s research activities meet IRS criteria for inclusion of these expenses.

Volunteering with the United States Pharmacopeia
By Chris Moreton, FinnBrit Consulting
The United States Pharmacopeia (USP) is one of three sets of official standards recognized under the US Food Drug and Cosmetic Act; the other two are the National Formulary (NF) and the Homeopathic Pharmacopeia of the United States. The USP is published by the United States Pharmacopeial Convention, Inc. (also called USP), headquartered in Rockville, MD. The current CEO of USP is Dr. Ron Piervincenzi. USP has a permanent staff and laboratories at its headquarters in Rockville, MD and satellite laboratories in China, India and Brazil. It also has further satellite office in Switzerland, Brazil and Ghana and it recently expanded its presence to Ethiopia, Indonesia, Nigeria and the Philippines. USP’s work is supported by a network of Expert Committees and Expert Panels staffed by volunteer experts. I have been a volunteer with USP since the year 2000.
The USP was first published in 1820. This makes it one of the oldest of the modern pharmacopeias. Originally, it was revised every 10 years. The first Committee of Revision was established in 1830. Later, it was revised every five years, and the USP continues to operate on a five-year Revision Cycle. However, the book is now revised and re-issued annually with two supplements per year. This change in the revision schedules reflects the increasing number, range and complexity of pharmaceutical products, the ever-increasing sophistication of drug substances, and the need for better specifications and control methods for modern medicines.
More infomation and How to Volunteer ...
 

 

THE COMMITTEE ON CHEMICAL ABSTRACTS WANTS YOUR FEEDBACK

Visit our page on ACS Network:
https://communities.acs.org/groups/chemical-abstracts-service-committee
or Contact Michael Filosa with any suggestions at
filosam@verizon.net
 

 
American Chemical Society
254th ACS National Meeting
Washington, District of Columbia
August 20-24, 2017
Councilor Talking Points; Summary of Governance Issues and Actions
Click to read full report ...
 

Historical Notes
Rose Reguera Simon James Edward Phillips Robert L. Lichter
Sandra Enrica Russo-Rodriguez Edward C. (Ted) Taylor William Klemperer
Marietta Schwartz Jean-Pierre Anselme Karen L. Piper
Christine Jaworek-Lopes Vivian Walworth Daniel J. Sandman
Arthur Obermayer Benedict Gallo Haig Markarian
Edwin Emerson Morse John J. Giuffrida Claude Spencer
Tommy Menino David O. Ham Norman J. Hochella
Bernard Siegal Clarence Grant Leon Mir